FIELD: pharmacology.
SUBSTANCE: present invention refers to pharmacology and discloses a nontoxic solid pharmaceutical composition for oral administration containing L-cysteine in combination with one or more additional active agents, at least one of which is selected from cystine, glutathione and methionine, as well as a non-toxic carrier.
EFFECT: composition provides reducing a frequency of severe headache, particularly migraine and/or cluster headache.
18 cl, 4 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF APPLICATION OF GUAVA EXTRACT AND COMPOSITION, WHICH INCLUDES GUAVA EXTRACT | 2007 |
|
RU2405564C2 |
| NICOTINE COMPOSITION FOR PERORAL APPLICATION, WHICH CONTAINS AMINO-ACID BUFFER | 2008 |
|
RU2465904C2 |
| NICOTINE-CONTAINING ORAL COATED COMPOUND WITH BUFFER PROPERTIES PROVIDED BY AMINO ACID | 2008 |
|
RU2476221C2 |
| TOBACCO PRODUCT FILTER | 2008 |
|
RU2463930C2 |
| COATED PHARMACEUTICAL PRODUCT FOR ORAL NICOTINE DELIVERY CONTAINING TROMETAMOL AS BUFFERING AGENT | 2007 |
|
RU2448707C2 |
| COMPOSITION FOR THE TREATMENT OF VEISALGIA | 2017 |
|
RU2757379C2 |
| PHARMACEUTICAL PRODUCT FOR INTRAORAL NICOTINE ADMINISTRATION CONTAINING TROMETAMOL AS BUFFER AGENT | 2007 |
|
RU2436566C2 |
| PHARMACEUTICAL COMPOSITION INDUCING GLUTATHIONE BIOSYNTHESIS, GLUTATHIONE TRANSFERASE ACTIVITY AND SHOWING ANTITOXIC, RADIOPROTECTIVE AND ANTIHYPOXIC ACTION AND METHODS OF TREATMENT, PROPHYLAXIS AND PROTECTION USING THEREOF | 1994 |
|
RU2096034C1 |
| MULTICOMPONENT ORAL DOSAGE FORM WITH ORGANOLEPTIC PROPERTIES | 2010 |
|
RU2490010C2 |
| ORAL COMPOSITIONS FOR SKIN IMPROVEMENT | 2010 |
|
RU2496488C2 |
